Four male participants were recruited for the pilot study. Before recruitment to this study, the participants were instructed to fast overnight. At recruitment, the male participants underwent a medical examination [height, weight, and body mass index (BMI) were measured]. For this study, the participants were recruited and admitted into hospital for a period of 36 hours. A blood sample was taken at a baseline (time zero), 2, 4, 8, 12 hour prior to the application of testosterone cream. Testosterone (50 mg in the form of Andromen ® 5% FORTE cream) was then immediately applied via transdermal route (topically). According to the manufacturer's information, a once off daily dose of 50 mg [4 cm applied to the trunk (side of body above hips)] will increase serum testosterone concentrations in testosterone deficient men into the mid-normal range. The participants were bled again at 2, 4, 6, 8, 10, 12, 16, 20 and 24 hours post application. The level of serum testosterone was measured for all the blood samples taken as shown in figure below (Fig. 1S) .
SHORT-TERM (PILOT) HUMAN STUDY 1
Four male participants were recruited for the pilot study. Before recruitment to this study, the participants were instructed to fast overnight. At recruitment, the male participants underwent a medical examination [height, weight, and body mass index (BMI) were measured]. For this study, the participants were recruited and admitted into hospital for a period of 36 hours. A blood sample was taken at a baseline (time zero), 2, 4, 8, 12 hour prior to the application of testosterone cream. Testosterone (50 mg in the form of Andromen ® 5% FORTE cream) was then immediately applied via transdermal route (topically). According to the manufacturer's information, a once off daily dose of 50 mg [4 cm applied to the trunk (side of body above hips)] will increase serum testosterone concentrations in testosterone deficient men into the mid-normal range. The participants were bled again at 2, 4, 6, 8, 10, 12, 16, 20 and 24 hours post application. The level of serum testosterone was measured for all the blood samples taken as shown in figure below (Fig. 1S) . 
SHORT-TERM (PILOT) HUMAN STUDY 2
As the preliminary result of the first pilot study indicated that application of testosterone cream on the side of the trunk (above hip) had a fluctuation or inconsistencies on increasing blood testosterone levels, the pilot study was repeated. In this second pilot study, testosterone (50 mg in the form of Andromen ® 5% FORTE cream) was applied on the scrotum to maximise the absorption of the testosterone cream on the skin, as this is an area which contains minimal body fat, has thin skin and a good blood supply. The same particpants as in pilot study 1 underwent the same treatment regime, sample collection as above and again testosterone levels was assessed. The level of serum testosterone was measured and the results indicated efficient and consistent absorption of the cream, as shown in Fig. (2S) below. Fig. (2S) . Short term (pilot) human study 2. Testosterone (50 mg in the form of Andromen ® 5% FORTE cream) was applied 4 cm applied on the scrotum. Application to scrotum resulted in a more consistent increasing testosterone levels within 24 hour compare to the trunk.
